The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.90
Ask: 34.25
Change: 0.00 (0.00%)
Spread: 0.35 (1.032%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 34.00
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Contract

28 Mar 2007 07:02

IQE PLC28 March 2007 28 March 2007 IQE plc IQE secures $US2.4m development contracts IQE plc (AIM: IQE), the leading global supplier of advanced wafer products andwafer services to the semiconductor industry, has secured two 12-monthdevelopment contracts worth in aggregate over $2.4m during 2007. The Group alsotoday published its preliminary results for the year to 31 December 2006 whichshowed revenues up 55.2% to £32.4m (2005: £20.9m) and a gross profit of £2.5m(2005: loss £0.8m) - see separate statement. The contracts have been awarded to develop materials for use in next generationof ultra high speed integrated circuits (IC). One contract is focused on the development of Strontium Titanium Oxide onSilicon epi-wafers (STO/Si) using IQE's state of the art molecular beam epitaxy(MBE) systems. IQE will further develop STO/Si deposition by MBE in order toprovide world-class compositional and surface quality control as a pre requisiteto future high volume production. The other contract is to develop advanced material structures for increasedprocessing speed for future ICs. These awards add to the current R&D contracts currently being serviced acrossthe Group, bringing the total awards to date for delivery in 2007 to almost $US5million. Dr Drew Nelson, IQE Chief Executive, commented: "We plan to aggressively pursue the metal-oxide on Silicon market where we offerunique and superior solutions for these advanced state of the art materialssystems. Our entry into this market is important as it further diversifies theGroup's product portfolio and underscores our position as the global leader inadvanced semiconductor wafer production and R&D." Contacts: IQE plc : Drew Nelson, President & Chief Executive Officer +44 (0)29 2083 9400Phillip Rasmussen, Chief Finance OfficerChris Meadows, Investor Relations Executive Noble + 44 (0) 20 7763 2200John Llewellyn-Lloyd College Hill +44 (0)20 7457 2020Adrian Duffield/Ben Way NOTE TO EDITORS IQE is the leading global supplier of advanced semiconductor wafers, withproducts that cover the whole spectrum of wafer structures, supported by aninnovative outsourced foundry services portfolio that allows the Group toprovide a "one stop shop" for the wafer needs of the world's leadingsemiconductor manufacturers. IQE uses advanced crystal growth technology (epitaxy) to manufacture and supplybespoke semiconductor wafers ("epi-wafers") to the major chip manufacturingcompanies, who then use these wafers to make the chips which form the keycomponents of virtually all high technology systems. IQE is unique in being ableto supply wafers using all of the leading crystal growth technology platforms. IQE's products are found in many leading-edge consumer, communication, computingand industrial applications, including a complete range of wafer products forthe wireless industry, such as mobile handsets and wireless infrastructure,WiFi, WiMAX, base stations, GPS, and satellite communications; opticalcommunications, optical storage (CD, DVD), laser optical mouse, laser printers &photocopiers, thermal imagers, leading-edge medical products, barcode, highefficiency LEDs and a variety of advanced silicon based systems. The manufacturers of these chips are increasingly seeking to outsource waferproduction to specialist foundries such as IQE in order to reduce overall wafercosts and accelerate time to market. IQE also provides bespoke R&D services to deliver customised materials forspecific applications and offers specialist technical staff to manufacture tospecification either at its own facilities or on the customer's own sites. TheGroup is also able to leverage its global purchasing volumes to reduce the costof raw materials. In this way IQE's outsourced services, provide compellingbenefits in terms of flexibility and predictability of cost, therebysignificantly reducing operating risk. IQE employs around 320 people and operates six manufacturing facilities locatedin Cardiff (two) and Milton Keynes in the UK; in Bethlehem, Pennsylvania andSomerset, New Jersey in the USA; and Singapore. The Group also has nine salesoffices located in major economic centres worldwide. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Aug 20137:00 amRNSIQE reports new CPV cell efficiency
5th Jun 20132:22 pmRNSMerger Update
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.